✦ LIBER ✦

Epidermal growth factor receptors in human breast cancer

✍ Scribed by Rolando Pérez; María Pascual; Amparo Macías; Agustín Lage

Publisher: Springer US
Year: 1984
Tongue: English
Weight: 395 KB
Volume: 4
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor-like activity an

Epidermal growth factor-like activity and epidermal growth factor-receptors in human primary breast cancer

✍ Zsuzsanna Kahán; Mária Szücs; Miklós Vecsernyés; Sándor Eckhardt 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 520 KB

Epidermal growth factor receptor in huma

Epidermal growth factor receptor in human breast cancers: Correlation with estrogen and progesterone receptors

✍ J. C. Delarue; S. Friedman; H. Mouriesse; F. May-Levin; H. Sancho-Garnier; G. Co 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 556 KB

Epidermal growth factor receptor and pro

Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study

✍ P. G. Koenders; L. V. A. M. Beex; C. B. M. Kienhuis; P. W. C. Kloppenborg; Th. J 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 588 KB

Relationship between epidermal growth fa

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer

✍ Masakazu Toi; Takashi Nakamura; Hidenori Mukaida; Tsutomu Wada; Akihiko Osaki; H 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Clinical value of enzyme immunoassay of

Clinical value of enzyme immunoassay of epidermal growth factor receptor in human breast cancer

✍ Hirotaka Iwase; Shunzo Kobayashi; Yukashi Itoh; Tatsuya Kuzushima; Hiroko Yamash 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 499 KB

Comparison of radioligand assay and immu

Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer

✍ D. J. Hastrich; J. M. Dunn; S. Nicholson; P. Newcomb; Professor J. R. Farndon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB 👁 2 views

## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche